Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.00+0.09 (+3.09%)
Close on Nov 17, 2026Market cap $11.85MP/E –Yield –
Onconetix total assets
Total assets on the balance sheet at the end of each period.
Onconetix's total assets was $16.43M at Jun 30, 2026. For fiscal 2025 it was $24.93M, down 11.5% from the year before. The highest annual figure on record is $87.52M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.93M | -11.5% |
| FY2024 | Dec 31, 2024 | $28.18M | -67.8% |
| FY2023 | Dec 31, 2023 | $87.52M | +232.6% |
| FY2022 | Dec 31, 2022 | $26.31M | +752.9% |
| FY2021 | Dec 31, 2021 | $3.08M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $16.43M | -14.1% |
| Q1 FY2026 | Mar 31, 2026 | $14.83M | -21.0% |
| Q4 FY2025 | Dec 31, 2025 | $24.93M | -11.5% |
| Q3 FY2025 | Sep 30, 2025 | $19.68M | -68.2% |
| Q2 FY2025 | Jun 30, 2025 | $19.12M | -67.8% |
| Q1 FY2025 | Mar 31, 2025 | $18.78M | -75.0% |
| Q4 FY2024 | Dec 31, 2024 | $28.18M | -67.8% |
| Q3 FY2024 | Sep 30, 2024 | $61.92M | +122.1% |
| Q2 FY2024 | Jun 30, 2024 | $59.46M | +99.9% |
| Q1 FY2024 | Mar 31, 2024 | $75.03M | +185.2% |
| Q4 FY2023 | Dec 31, 2023 | $87.52M | +190.2% |
| Q3 FY2023 | Sep 30, 2023 | $27.88M | +18.0% |
| Q2 FY2023 | Jun 30, 2023 | $29.75M | +53.9% |
| Q4 FY2022 | Dec 31, 2022 | $26.31M | +752.9% |
| Q3 FY2022 | Sep 30, 2022 | $30.16M | – |
| Q2 FY2022 | Jun 30, 2022 | $23.63M | – |
| Q1 FY2022 | Mar 31, 2022 | $19.34M | – |
| Q4 FY2021 | Dec 31, 2021 | $3.08M | – |
See a number that looks wrong?